Predictive Model for Delivery Efficiency: Erythrocyte Membrane-Camouflaged Magnetofluorescent Nanocarriers Study

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacokinetics

Background:

• Nanoparticle (NP) delivery efficiency for passive tumor targeting relies on circulation time and tumor microenvironment modulation.
• Predicting NP delivery efficiency is crucial for optimizing cancer therapies.

Purpose of the Study:

• To develop a novel erythrocyte membrane-camouflaged magnetofluorescent nanocarrier (MMFn).
• To create an analytical pharmacokinetic (PK) model for predicting nanocarrier delivery efficiency (DE) and peak tumor uptake time (tmax).
• To evaluate the model's ability to predict changes in DE and tmax due to tumor microenvironment modulation.

Main Methods:

• Synthesis and characterization of MMFns incorporating manganese ferrite nanoparticles and IR-780 dye.
• In vitro analysis of MMFn properties (composition, morphology, optical, magnetic, thermal).
• Development and validation of an analytical PK model using Monolix software and comparison with numerical solutions.
• In vivo pharmacokinetic and biodistribution studies using fluorescence molecular tomography (FMT) and alternating current biosusceptometry (ACB).

Main Results:

• MMFns exhibited a long blood circulation time (92 h) and high delivery efficiency (10% ID in a murine tumor model).
• The developed PK model accurately predicted DE and tmax.
• The model successfully predicted changes in DE and tmax following tumor microenvironment modulation.
• In vivo studies confirmed the model's predictions and demonstrated effective tumor targeting.

Conclusions:

• The developed MMFn shows promise as a theranostic nanocarrier with enhanced tumor delivery.
• The analytical PK model provides a valuable tool for predicting and optimizing nanocarrier delivery efficiency.
• This approach facilitates the design of more effective nanomedicines for cancer therapy.